Measurable residual disease in elderly acute myeloid leukemia: Results from the PETHEMA-FLUGAZA phase 3 clinical trial

  1. Simoes, C.
  2. Paiva, B.
  3. Martínez-Cuadrón, D.
  4. Bergua, J.-M.
  5. Vives, S.
  6. Algarra, L.
  7. Tormo, M.
  8. Martinez, P.
  9. Serrano, J.
  10. Herrera, P.
  11. Ramos, F.
  12. Salamero, O.
  13. Lavilla, E.
  14. Gil, C.
  15. Lopez, J.-L.
  16. Vidriales, M.-B.
  17. Labrador, J.
  18. Falantes, J.-F.
  19. Sayas, M.-J.
  20. Ayala, R.
  21. Martinez-Lopez, J.
  22. Villar, S.
  23. Calasanz, M.-J.
  24. Prosper, F.
  25. San-Miguel, J.F.
  26. Sanz, M.Á.
  27. Montesinos, P.
  28. Show all authors +
Journal:
Blood Advances

ISSN: 2473-9537 2473-9529

Year of publication: 2021

Volume: 5

Issue: 3

Pages: 760-770

Type: Article

DOI: 10.1182/BLOODADVANCES.2020003195 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals